Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers

To support the implementation of genome-based precision medicine, we developed machine learning models that predict the recurrence of patients with gynecologic cancer in using immune checkpoint inhibitors (ICI) based on clinical and pathologic characteristics, including Lynch syndrome-related screen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Byung Wook Kim, Min Chul Choi, Min Kyu Kim, Jeong-Won Lee, Min Tae Kim, Joseph J. Noh, Hyun Park, Sang Geun Jung, Won Duk Joo, Seung Hun Song, Chan Lee
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/9f28b2f6609946aca0cf30a648f4b40c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9f28b2f6609946aca0cf30a648f4b40c
record_format dspace
spelling oai:doaj.org-article:9f28b2f6609946aca0cf30a648f4b40c2021-11-25T17:02:28ZMachine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers10.3390/cancers132256702072-6694https://doaj.org/article/9f28b2f6609946aca0cf30a648f4b40c2021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5670https://doaj.org/toc/2072-6694To support the implementation of genome-based precision medicine, we developed machine learning models that predict the recurrence of patients with gynecologic cancer in using immune checkpoint inhibitors (ICI) based on clinical and pathologic characteristics, including Lynch syndrome-related screening markers such as immunohistochemistry (IHC) and microsatellite instability (MSI) tests. To accomplish our goal, we reviewed the patient demographics, clinical data, and pathological results from their medical records. Then we identified seven potential characteristics (four MMR IHC [<i>MLH1, MSH2, MSH6,</i> and <i>PMS2</i>], MSI, Age 60, and tumor size). Following that, predictive models were built based on these variables using six machine learning algorithms: logistic regression (LR), support vector machine (SVM), naive Bayes (NB), random forest (RF), gradient boosting (GB), and extreme gradient boosting (EGB) (XGBoost). The experimental results showed that the RF-based model performed best at predicting gynecologic cancer recurrence, with AUCs of 0.818 and 0.826 for the 5-fold cross-validation (CV) and 5-fold CV with 10 repetitions, respectively. This study provides novel and baseline results about predicting the recurrence of gynecologic cancer in patients using ICI by using machine learning methods based on Lynch syndrome-related screening markers.Byung Wook KimMin Chul ChoiMin Kyu KimJeong-Won LeeMin Tae KimJoseph J. NohHyun ParkSang Geun JungWon Duk JooSeung Hun SongChan LeeMDPI AGarticlemachine learningimmune checkpoint inhibitorsLynch syndromerecurrenceNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5670, p 5670 (2021)
institution DOAJ
collection DOAJ
language EN
topic machine learning
immune checkpoint inhibitors
Lynch syndrome
recurrence
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle machine learning
immune checkpoint inhibitors
Lynch syndrome
recurrence
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Byung Wook Kim
Min Chul Choi
Min Kyu Kim
Jeong-Won Lee
Min Tae Kim
Joseph J. Noh
Hyun Park
Sang Geun Jung
Won Duk Joo
Seung Hun Song
Chan Lee
Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers
description To support the implementation of genome-based precision medicine, we developed machine learning models that predict the recurrence of patients with gynecologic cancer in using immune checkpoint inhibitors (ICI) based on clinical and pathologic characteristics, including Lynch syndrome-related screening markers such as immunohistochemistry (IHC) and microsatellite instability (MSI) tests. To accomplish our goal, we reviewed the patient demographics, clinical data, and pathological results from their medical records. Then we identified seven potential characteristics (four MMR IHC [<i>MLH1, MSH2, MSH6,</i> and <i>PMS2</i>], MSI, Age 60, and tumor size). Following that, predictive models were built based on these variables using six machine learning algorithms: logistic regression (LR), support vector machine (SVM), naive Bayes (NB), random forest (RF), gradient boosting (GB), and extreme gradient boosting (EGB) (XGBoost). The experimental results showed that the RF-based model performed best at predicting gynecologic cancer recurrence, with AUCs of 0.818 and 0.826 for the 5-fold cross-validation (CV) and 5-fold CV with 10 repetitions, respectively. This study provides novel and baseline results about predicting the recurrence of gynecologic cancer in patients using ICI by using machine learning methods based on Lynch syndrome-related screening markers.
format article
author Byung Wook Kim
Min Chul Choi
Min Kyu Kim
Jeong-Won Lee
Min Tae Kim
Joseph J. Noh
Hyun Park
Sang Geun Jung
Won Duk Joo
Seung Hun Song
Chan Lee
author_facet Byung Wook Kim
Min Chul Choi
Min Kyu Kim
Jeong-Won Lee
Min Tae Kim
Joseph J. Noh
Hyun Park
Sang Geun Jung
Won Duk Joo
Seung Hun Song
Chan Lee
author_sort Byung Wook Kim
title Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers
title_short Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers
title_full Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers
title_fullStr Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers
title_full_unstemmed Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers
title_sort machine learning for recurrence prediction of gynecologic cancers using lynch syndrome-related screening markers
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/9f28b2f6609946aca0cf30a648f4b40c
work_keys_str_mv AT byungwookkim machinelearningforrecurrencepredictionofgynecologiccancersusinglynchsyndromerelatedscreeningmarkers
AT minchulchoi machinelearningforrecurrencepredictionofgynecologiccancersusinglynchsyndromerelatedscreeningmarkers
AT minkyukim machinelearningforrecurrencepredictionofgynecologiccancersusinglynchsyndromerelatedscreeningmarkers
AT jeongwonlee machinelearningforrecurrencepredictionofgynecologiccancersusinglynchsyndromerelatedscreeningmarkers
AT mintaekim machinelearningforrecurrencepredictionofgynecologiccancersusinglynchsyndromerelatedscreeningmarkers
AT josephjnoh machinelearningforrecurrencepredictionofgynecologiccancersusinglynchsyndromerelatedscreeningmarkers
AT hyunpark machinelearningforrecurrencepredictionofgynecologiccancersusinglynchsyndromerelatedscreeningmarkers
AT sanggeunjung machinelearningforrecurrencepredictionofgynecologiccancersusinglynchsyndromerelatedscreeningmarkers
AT wondukjoo machinelearningforrecurrencepredictionofgynecologiccancersusinglynchsyndromerelatedscreeningmarkers
AT seunghunsong machinelearningforrecurrencepredictionofgynecologiccancersusinglynchsyndromerelatedscreeningmarkers
AT chanlee machinelearningforrecurrencepredictionofgynecologiccancersusinglynchsyndromerelatedscreeningmarkers
_version_ 1718412792778719232